East Coast Institute For Research
Biotechnology ResearchFlorida, United States11-50 Employees
East Coast Institute for Research (ECIR) operates within the biotechnology research sector, providing Phase II–IV clinical trial services across multiple therapeutic areas. As a member of the Rovia Clinical Research Site Network, ECIR combines local clinical expertise with national infrastructure to support both sponsor- and investigator-initiated studies, aiming to accelerate clinical development while maintaining patient safety and quality trial execution. Based in Jacksonville, Florida, with multiple research offices in the region, the institute emphasizes streamlined operations, rigorous oversight by board-certified investigators, and active community engagement in its trial processes. ECIR targets pharmaceutical sponsors, contract research organizations, and investigators seeking efficient enrollment and diverse patient access, leveraging its network partnership to improve startup speed and enrollment outcomes. The organization situates itself in the biotechnology research landscape as a mid-sized player delivering late-phase clinical trials, and it operates in a geographically focused area in northern Florida. A recent development notes Gauge Capital LLC’s investment activity related to ECIR, reflecting external interest in the organization within the healthcare and life sciences ecosystem.